Form D · Pharmaceuticals
Vantage Health
Los Angeles, CA · CIK 0001497130
Offering snapshot reported Oct 14, 2010 · SEC filing
- Reported sold
- $4.89K Offering amount: $4.89K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $150 Reported outside-investor minimum
- First sale
- Jun 26, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2010 | Initial | $4,890 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149053
No Commissions of fees have been paid to anyone group or people
Source: Form D, filed Oct 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lisa Ramakrishnan | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11400 Olympic Blvd., Suite 640
Los Angeles, CA, 90064
Los Angeles, CA, 90064